Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2851 (LINC02851)

Target
LINC02851
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2851 (LINC02851) is classified as a long intergenic non-coding RNA (lincRNA), meaning it is a non-coding RNA transcript longer than 200 nucleotides, which does not overlap with protein-coding regions of the genome[1][5]. LincRNAs typically function in the regulation of gene expression at transcriptional and epigenetic levels, potentially influencing chromatin structure and interacting with DNA, RNA, or protein complexes[5]. While the general role of lincRNAs includes involvement in diverse processes such as chromatin remodeling, transcriptional regulation, and gene expression modulation, there is currently no specific functional or disease association curated for LINC02851 itself[1]. There is no evidence that this molecule is a conventional therapeutic target such as a receptor, enzyme, or transporter. LINC02851 has not been characterized in terms of direct involvement in drug response, therapeutic applications, or as a biomarker. Like many annotated lincRNAs, its biological functions remain largely uncharacterized, and it is not conventionally considered a therapeutic target[1][5].

Other names
LINC02851long intergenic non-protein coding RNA 2851
02

Biological functions

Regulation of gene expression (based on typical lincRNA function)Chromatin remodeling (potential, by analogy to other lincRNAs)Transcriptional regulation (potential, by analogy)
03

Disease associations

Not specifically characterized for LINC02851; however, lincRNAs as a class have been implicated in cancer and other diseases

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2851 (LINC02851).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2851 (LINC02851).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call